Skip to main content
Supplement ScienceSupplementScience

Types of AREDS2 Formula: Forms & Bioavailability

Evidence:Strong
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Forms Comparison

FormBioavailabilityBest For
AREDS2 Soft Gels (standard)HighStandard supplementation — 2 soft gels daily provide the full AREDS2 dose
AREDS2 Chewable TabletsModerate-HighThose who have difficulty swallowing large capsules
AREDS2 + Additional NutrientsHighEnhanced formulas — some products add omega-3s, meso-zeaxanthin, or astaxanthin

AREDS2 Soft Gels (standard)

Bioavailability: High. Best for: Standard supplementation — 2 soft gels daily provide the full AREDS2 dose.

AREDS2 Chewable Tablets

Bioavailability: Moderate-High. Best for: Those who have difficulty swallowing large capsules.

AREDS2 + Additional Nutrients

Bioavailability: High. Best for: Enhanced formulas — some products add omega-3s, meso-zeaxanthin, or astaxanthin.

Full AREDS2 Formula Guide

References

  1. RCTAge-Related Eye Disease Study 2 Research Group (2013). Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. DOI PubMed
  2. RCTChew EY, Clemons TE, Agrón E, et al. (2022). Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28. JAMA Ophthalmology. DOI PubMed
  3. RCTAge-Related Eye Disease Study Research Group (2001). A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss: AREDS Report No. 8. Archives of Ophthalmology. DOI PubMed